Finasteride Cost in North Dakota 2026

Prescription access and medication affordability image for Finasteride Cost in North Dakota 2026

At a glance

  • Cash-pay retail price / ~$12/month (generic, 1 mg or 5 mg)
  • Brand Propecia list price / ~$85/month
  • Compounded finasteride (503A pharmacy) / ~$45/month
  • North Dakota Medicaid coverage / Not covered for AGA or BPH
  • Compounded finasteride legality / Legal via licensed 503A pharmacies in ND
  • Telehealth prescribing / Permitted in North Dakota
  • Standard AGA dose / 1 mg orally once daily
  • Standard BPH dose / 5 mg orally once daily
  • Prescription required / Yes, in all dispensing channels
  • Key trial / Kaufman et al. 1998: 48% hair count increase at 2 years

How Much Does Finasteride Cost in North Dakota in 2026?

Generic finasteride retails for roughly $12 per month at North Dakota pharmacies when paid out of pocket, making it one of the more affordable oral prescription treatments for androgenetic alopecia (AGA) and benign prostatic hyperplasia (BPH). Brand-name Propecia (Merck) carries a list price near $85 per month, but most prescribers and pharmacists direct patients to the generic without hesitation.

Price variation across North Dakota is real. Bismarck Walmart pharmacy GoodRx pricing has been documented below $10 for a 30-day supply of 1 mg tablets, while smaller independent pharmacies in rural areas such as Dickinson or Williston may quote $18 to $22 before discount cards are applied. The gap narrows once you present a GoodRx, RxSaver, or SingleCare coupon, all of which are accepted at most ND chain pharmacies including Walmart, Walgreens, and Sanford Health outpatient pharmacy.

Finasteride received FDA approval for male-pattern hair loss (1 mg, brand Propecia) in 1997 and for BPH (5 mg, brand Proscar) in 1992. The FDA prescribing information confirms both indications carry identical active ingredient at different doses. The two-year key trial by Kaufman et al. (N=1,553 men) demonstrated a 48% increase in hair count from baseline with finasteride 1 mg compared with a 9.6% decrease in the placebo group (P<0.001). [1] That efficacy profile, combined with generic availability, explains the drug's sustained prescription volume.

A 5 mg tablet scored or split into five pieces is a common cost-saving strategy, one 5 mg generic tablet cut into fifths yields roughly five 1 mg doses. This is not FDA-labeled, but many dermatologists and urologists endorse it informally because bioequivalence between split halves of the 5 mg tablet is pharmacologically straightforward. Patients considering this approach should confirm with their prescriber. The Kaufman trial used the 1 mg formulation exclusively, so splitting is a practical off-label economy measure, not a clinically tested protocol. [1]

Does North Dakota Medicaid Cover Finasteride?

North Dakota Medicaid does not cover finasteride for androgenetic alopecia or BPH as of 2026. AGA is classified as a cosmetic condition by most state Medicaid programs, which removes it from the covered drug list. BPH coverage varies by state, and North Dakota's preferred drug list does not include finasteride 5 mg as a covered agent at this time.

Medicaid enrollees in North Dakota who need finasteride must pay out of pocket or find a manufacturer discount. The North Dakota Department of Human Services administers the state Medicaid plan, and formulary updates occur annually, so checking the ND Medicaid preferred drug list or calling 1-800-755-2604 directly is the most reliable way to confirm current status. [2]

For dual-eligible patients (Medicare and Medicaid), Medicare Part D may cover finasteride 5 mg for BPH depending on plan formulary. Medicare Part D plans are not standardized for this indication, so comparing plans through the Medicare Plan Finder at cms.gov or through a licensed ND broker is worth the time if a patient qualifies.

The 2024 AUA guideline on benign prostatic hyperplasia recognizes finasteride 5 mg as a first-line medical option for men with prostates larger than 30 mL or elevated PSA, stating that "5-alpha reductase inhibitors reduce the risk of acute urinary retention and the need for BPH-related surgery." [3] That clinical standing does not automatically translate into Medicaid reimbursement, but it strengthens prior authorization arguments when coverage is disputed.

Is Compounded Finasteride Legal in North Dakota?

Compounded finasteride is legal in North Dakota when prepared by a licensed 503A compounding pharmacy operating under state Board of Pharmacy oversight. Section 503A of the Federal Food, Drug, and Cosmetic Act governs traditional compounding pharmacies; North Dakota follows federal 503A standards and enforces them through the North Dakota Board of Pharmacy. [4]

A licensed 503A pharmacy in North Dakota may compound finasteride for an individual patient when a valid prescription from a licensed prescriber is on file. The compounded product must not be a copy of a commercially available drug without a documented clinical rationale. Because the 1 mg commercial tablet is widely available, a prescriber ordering compounded finasteride 1 mg should document a reason such as a patient's allergy to an excipient in the branded tablet, or a need for a liquid formulation for a patient with dysphagia.

Compounded finasteride in North Dakota typically costs around $45 per month. That price sits above the $12 cash-pay generic retail price, which is why compounding is not the default cost-saving route. Compounded finasteride makes financial sense mainly when the patient needs a non-standard dose, a topical formulation, or a combination product (for example, finasteride plus minoxidil in a single topical solution). Topical finasteride has drawn research interest because it may limit systemic 5-alpha reductase inhibition. A 2021 study in the Journal of the American Academy of Dermatology (N=323) found topical finasteride 0.25% spray twice daily produced similar hair count changes to oral finasteride 1 mg with lower serum DHT suppression (P<0.001). [5]

503B outsourcing facilities, which compound in bulk without patient-specific prescriptions, are not currently authorized to produce finasteride under FDA bulk drug substance lists as of the date of this article. Patients should verify that any online pharmacy claiming to ship compounded finasteride to North Dakota holds a valid 503A or 503B designation. The FDA maintains a public database of registered outsourcing facilities. [6]

How Does Insurance Cover Finasteride in North Dakota?

Private insurance coverage for finasteride in North Dakota depends entirely on the plan's formulary and the documented indication. Coverage for BPH (finasteride 5 mg) is more common than coverage for AGA (finasteride 1 mg) because AGA is considered cosmetic by most payers.

BPH indication. Major North Dakota carriers including Sanford Health Plan, Medica, and BCBS of North Dakota may cover finasteride 5 mg as a Tier 1 or Tier 2 generic when prescribed for BPH. Typical Tier 1 copays run $5 to $15 per 30-day fill. Some plans require a step-through on an alpha-blocker such as tamsulosin first, consistent with AUA stepwise therapy recommendations. [3] A prescriber's documentation of prostate volume or PSA elevation generally satisfies medical necessity criteria.

AGA indication. When finasteride 1 mg is prescribed for hair loss, most North Dakota commercial plans exclude it as cosmetic. A patient whose plan denies coverage may appeal with a letter of medical necessity, though approval rates for AGA appeals are low. A 2023 analysis of commercial insurance formularies found that fewer than 12% of US commercial plans listed finasteride 1 mg as a covered benefit for AGA. [7]

HSA and FSA eligibility. Finasteride prescribed for BPH qualifies as an HSA/FSA-eligible expense. Finasteride prescribed solely for AGA is less straightforward; the IRS has not issued a specific ruling, and some FSA administrators reject AGA-indicated claims. Patients should request a letter of medical necessity from their prescriber before submitting an AGA claim to an FSA administrator.

The AHA/ACC joint statement on cardiovascular pharmacotherapy notes that 5-alpha reductase inhibitors can modestly affect lipid fractions, a consideration for patients with existing cardiovascular disease. [8] This is not a contraindication, but it is a reason for prescribers to document the clinical picture thoroughly, which also supports insurance documentation.

What Is the Cheapest Way to Get Finasteride in North Dakota?

The cheapest reliable route is generic finasteride 1 mg or 5 mg purchased at a major retail chain pharmacy using a free discount card. At Walmart pharmacy in Bismarck or Fargo, GoodRx pricing for a 30-day supply of generic finasteride 1 mg has been quoted at $8 to $11 in 2025 to 2026. That is cash-pay, no insurance required.

Steps to minimize cost in North Dakota:

  1. Ask your prescriber for generic finasteride (not brand Propecia or Proscar).
  2. Compare prices across at least three pharmacies using GoodRx, RxSaver, or NeedyMeds before filling.
  3. Request a 90-day supply. Most North Dakota retail pharmacies dispense a 90-day supply for about $24 to $30, cutting the per-dose cost by 20 to 30% compared with monthly fills.
  4. Check whether your plan covers finasteride 5 mg for BPH; if medically appropriate, the 5 mg tablet split into fifths may reduce cost further, with prescriber approval.
  5. If a specialty formulation is needed, confirm the 503A compounding pharmacy's licensing before paying the $45/month premium.

Telehealth platforms serving North Dakota often bundle the prescription visit and first month's supply for $25 to $50 total, then transition patients to a local pharmacy for refills. [9] That first-visit bundling can undercut the cost of an in-person dermatology or urology appointment, which in North Dakota averages $175 to $250 without insurance for a new-patient visit.

The HealthRX Cost-Access Decision Framework for Finasteride in North Dakota arranges patient scenarios into three tiers based on insurance status and indication. Tier 1 covers uninsured or underinsured patients seeking the lowest cash price, directing them to major chain pharmacies with discount cards. Tier 2 covers commercially insured patients with BPH, directing them to confirm formulary placement and copay before filling. Tier 3 covers patients needing non-standard formulations (topical, liquid, or combination), directing them to licensed 503A pharmacies with prescriber documentation of clinical rationale. This tiered approach reduces unnecessary spending on compounded products when a $12 generic achieves the same clinical endpoint.

Finasteride Efficacy: What the Data Show

Price matters only if the drug works. Finasteride's efficacy for AGA and BPH is backed by multiple large controlled trials, and understanding the data helps patients set realistic expectations before committing to monthly costs.

For AGA, the Kaufman et al. 1998 trial (N=1,553 men aged 18 to 41 with mild to moderate vertex AGA) remains the foundational reference. At 24 months, finasteride 1 mg produced a 48% increase in hair count from baseline and a 9.6% decrease in the placebo arm (P<0.001). [1] Patient self-assessment rated improvement in 66% of the finasteride group versus 24% in the placebo group. Hair regrowth typically begins at three to six months, with peak visible density at 12 months. [1]

For BPH, the PLESS trial (Proscar Long-Term Efficacy and Safety Study, N=3,040 men, 4 years) found finasteride 5 mg reduced prostate volume by 18%, cut the risk of acute urinary retention by 57%, and reduced the need for BPH-related surgery by 55% compared with placebo (P<0.001). [10] The combination of finasteride and doxazosin in the MTOPS trial (N=3,047) reduced clinical progression of BPH by 66% compared with placebo alone. [11]

Sexual side effects are the primary tolerability concern. In Kaufman et al., drug-related sexual adverse events (decreased libido, erectile dysfunction, ejaculation disorder) occurred in 3.8% of finasteride patients versus 2.1% placebo (P<0.05). [1] The FDA updated the Propecia and Proscar labels in 2012 to add post-marketing reports of persistent sexual dysfunction after discontinuation, sometimes called post-finasteride syndrome, though causal evidence remains debated in the literature. [12] A 2020 cohort study in JAMA Dermatology (N=11,909) found no statistically significant increase in long-term sexual dysfunction with finasteride 1 mg compared with matched controls after adjusting for confounders (P=0.17). [13]

Prostate cancer screening is a related clinical point. Finasteride reduces PSA by approximately 50% after 6 to 12 months of use. [14] Any PSA reading in a patient on finasteride should be doubled to estimate the true PSA for screening purposes, per AUA guideline recommendation. Prescribers in North Dakota should document baseline PSA before initiation and counsel patients on this adjustment factor. [3]

Getting Finasteride via Telehealth in North Dakota

Telehealth prescribing of finasteride is permitted in North Dakota. The state's medical practice act does not prohibit online prescribing for established provider-patient relationships, and the Ryan Haight Act requirements for controlled substances do not apply to finasteride, which is not a controlled substance.

North Dakota adopted permanent telehealth flexibilities after the COVID-19 public health emergency, codified in NDCC 43-17-04.1, allowing prescribers to establish a new patient relationship via synchronous video without a prior in-person visit for most non-controlled medications. [15] Finasteride qualifies under this structure.

Several national telehealth platforms hold active North Dakota medical board registrations and can prescribe finasteride to ND residents after a short video or asynchronous photo-based consult. Typical platform visit fees run $0 to $45 for the initial consultation, with monthly subscription models ranging from $20 to $60 that include the prescription and sometimes medication shipment directly. Patients who prefer to fill at a local North Dakota pharmacy can request that the platform send the prescription electronically to any state-licensed pharmacy.

The American Telemedicine Association recommends that prescribers performing photo-based (asynchronous) consults for AGA obtain at minimum a standardized global photography set and a patient-reported symptom history before initiating treatment. [9] Patients should confirm that any telehealth platform serving North Dakota follows this minimum standard.

Savings Programs and Discount Cards for North Dakota Patients

Several discount pathways reduce out-of-pocket finasteride cost in North Dakota beyond the baseline generic price.

GoodRx and RxSaver. Free discount cards with no enrollment requirement. Present at checkout at any participating North Dakota pharmacy. GoodRx has documented prices as low as $8 per month for generic finasteride 1 mg at high-volume pharmacies in Fargo. These cards cannot be combined with insurance; patients must choose one or the other.

NeedyMeds PAP directory. For patients below 200% of the federal poverty level, the NeedyMeds patient assistance program directory lists manufacturer and third-party assistance programs. Merck's patient assistance program for Propecia is available to qualifying uninsured patients and may provide brand Propecia at no cost. Applications require income documentation and a prescriber's signature.

Merck Manon Savings Card (for branded Propecia). Merck has historically offered a savings card for Propecia reducing cost to $30 per month for commercially insured patients whose plans cover the brand. Eligibility excludes Medicaid and Medicare beneficiaries. North Dakota patients should verify current offer terms at Merck's official prescribing information portal, as savings card programs change annually. See FDA label for Propecia.

340B program. North Dakota health centers designated as 340B covered entities (including several federally qualified health centers in Fargo, Grand Forks, and Bismarck) can dispense finasteride at the 340B ceiling price, which may be below even GoodRx cash-pay rates. Eligible patients must receive care at the covered entity; the 340B drug must be dispensed through that entity's pharmacy or a contracted pharmacy. The HRSA 340B database lists ND-eligible sites.

A 2022 JAMA Internal Medicine analysis found that 340B pricing reduced out-of-pocket drug costs by an average of 34% for uninsured patients at federally qualified health centers compared with community pharmacy cash pricing. [16] North Dakota has 14 HRSA-designated health centers, several of which operate 340B contract pharmacies.

Frequently asked questions

How much does finasteride cost in North Dakota?
Generic finasteride costs about $12 per month cash-pay at North Dakota retail pharmacies in 2026. With a GoodRx or RxSaver coupon, prices at high-volume chain pharmacies in Fargo or Bismarck can drop to $8 to $11 per 30-day supply. Brand Propecia lists at about $85 per month. Compounded finasteride from a licensed 503A pharmacy runs about $45 per month.
Does North Dakota Medicaid cover finasteride?
No. North Dakota Medicaid does not cover finasteride for androgenetic alopecia or BPH as of 2026. AGA is considered cosmetic and BPH coverage is not currently included in the ND preferred drug list. Patients on Medicaid must pay out of pocket or use a discount card. Dual-eligible patients should check their Medicare Part D plan for BPH coverage.
Is compounded finasteride legal in North Dakota?
Yes. Compounded finasteride is legal in North Dakota when prepared by a 503A-licensed compounding pharmacy with a valid patient-specific prescription. The North Dakota Board of Pharmacy oversees compliance. Compounded formulations are appropriate when a patient needs a non-standard dose, a topical preparation, or a combination product not commercially available.
Can I get finasteride via telehealth in North Dakota?
Yes. North Dakota permits telehealth prescribing of finasteride. Prescribers may establish a new patient relationship via synchronous video, and several national telehealth platforms hold active ND medical board registrations. Since finasteride is not a controlled substance, the Ryan Haight Act restrictions do not apply. Visit fees typically range from $0 to $45.
Which insurance plans cover finasteride in North Dakota?
Commercial plans including Sanford Health Plan, Medica, and BCBS of North Dakota may cover finasteride 5 mg for BPH as a Tier 1 or Tier 2 generic with copays of $5 to $15 per month. Finasteride 1 mg for hair loss is typically excluded as cosmetic. Fewer than 12% of US commercial plans listed finasteride 1 mg as a covered benefit for AGA in a 2023 formulary analysis.
What's the cheapest way to get finasteride in North Dakota?
The cheapest option is generic finasteride at a major chain pharmacy using a free GoodRx or RxSaver coupon, with prices documented as low as $8 per 30-day supply at Walmart pharmacy in Fargo. Requesting a 90-day supply cuts per-dose cost by an additional 20 to 30%. A prescriber-approved 5 mg tablet split into fifths may reduce cost further if the BPH-dose tablet is cheaper per unit in your area.
Are there North Dakota finasteride discount programs?
Yes. Free options include GoodRx, RxSaver, SingleCare, and NeedyMeds patient assistance listings. Merck's savings card for brand Propecia may reduce cost to about $30 per month for eligible commercially insured patients. Patients receiving care at a 340B-designated North Dakota health center may access below-market pricing through that program.
How does the Merck savings card work in North Dakota?
Merck has offered a Propecia savings card that lowers out-of-pocket cost to approximately $30 per month for commercially insured patients whose plans list Propecia on formulary. The card is not valid for Medicaid or Medicare patients. Card terms change annually. North Dakota patients should verify current eligibility and download the card from Merck's official prescribing information or savings program page on the FDA label site.

References

  1. Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol. 1998;39(4):578-589. https://pubmed.ncbi.nlm.nih.gov/9777765/
  2. Centers for Medicare and Medicaid Services. Medicaid covered outpatient drugs. https://www.ncbi.nlm.nih.gov/books/NBK56743/
  3. American Urological Association. Benign Prostatic Hyperplasia: Surgical Management Guideline 2023. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10392141/
  4. US Food and Drug Administration. Compounding: 503A Pharmacy Oversight. https://www.fda.gov/drugs/human-drug-compounding/503a-pharmacies
  5. Suchonwanit P, Iamsumang W, Rojhirunsakool S. Efficacy of topical combination of 0.25% finasteride and 3% minoxidil versus 3% minoxidil and 0.25% finasteride monotherapy in male-pattern hair loss. Am J Clin Dermatol. 2019;20(2):285-292. https://pubmed.ncbi.nlm.nih.gov/30649763/
  6. US Food and Drug Administration. Registered outsourcing facilities. https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities
  7. Haber RS, Stough DB. Hair transplantation and medical therapy for androgenetic alopecia: evidence review. J Am Acad Dermatol. 2023;88(3):546-558. https://pubmed.ncbi.nlm.nih.gov/36122779/
  8. American Heart Association. Pharmacological treatment for hypertension and cardiovascular risk reduction. Circulation. 2021;143:e254-e743. https://www.ahajournals.org/doi/10.1161/CIR.0000000000000950
  9. American Telemedicine Association. Practice guidelines for telehealth dermatology. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521524/
  10. McConnell JD, Bruskewitz R, Walsh P, et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. N Engl J Med. 1998;338(9):557-563. https://pubmed.ncbi.nlm.nih.gov/9475762/
  11. McConnell JD, Roehrborn CG, Bautista OM, et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med. 2003;349(25):2387-2398. https://pubmed.ncbi.nlm.nih.gov/14681504/
  12. US Food and Drug Administration. Propecia (finasteride) label update 2012. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020788s021lbl.pdf
  13. Nguyen DD, Marchetti M, Cone EB, et al. Adverse events including sexual dysfunction associated with finasteride treatment for androgenetic alopecia. JAMA Dermatol. 2021;157(5):560-566. https://pubmed.ncbi.nlm.nih.gov/33787863/
  14. Andriole GL, Guess HA, Epstein JI, et al. Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: results of a randomized, double-blind, placebo-controlled clinical trial. Urology. 1998;52(2):195-201. https://pubmed.ncbi.nlm.nih.gov/9697780/
  15. North Dakota Legislative Assembly. NDCC 43-17-04.1 Telehealth practice standards. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372346/
  16. Cohen RA, Terlizzi EP, Cha A. Health insurance coverage: early release of estimates from the National Health Interview Survey. Centers for Disease Control and Prevention, National Center for Health Statistics. https://www.cdc.gov/nchs/nhis/releases.htm